De novo and secondary anaplastic meningiomas: a study of clinical and histomolecular prognostic factors | Zendy

Matthieu Peyre | Zendy; Guillaume Gauchotte | Zendy; Marine Giry | Zendy; Sébastien Froehlich | Zendy; Johan Pallud | Zendy; Thomas Graillon | Zendy; Franck Bielle | Zendy; Dominique CazalsHatem | Zendy; Pascale Varlet | Zendy; Dominique FigarellaBranger | Zendy; Hugues Loiseau | Zendy; Michel Kalamarides | Zendy

AI Assistant Blog Pricing

Open Access

De novo and secondary anaplastic meningiomas: a study of clinical and histomolecular prognostic factors

Author(s) -

Matthieu Peyre,

Guillaume Gauchotte,

Marine Giry,

Sébastien Froehlich,

Johan Pallud,

Thomas Graillon,

Franck Bielle,

Dominique CazalsHatem,

Pascale Varlet,

Dominique FigarellaBranger,

Hugues Loiseau,

Michel Kalamarides

Publication year - 2017

Publication title -

neuro-oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.005

H-Index - 125

eISSN - 1523-5866

pISSN - 1522-8517

DOI - 10.1093/neuonc/nox231

Subject(s) - anaplasia , meningioma , medicine , oncology , overall survival , survival analysis , pathology

Following recent studies underlining the differences between de novo and secondary anaplastic meningiomas and the prognostic value of telomerase reverse transcriptase (TERT) promoter mutation, we decided to conduct a multicenter retrospective study to address these questions and determine specific prognostic factors in each of these 2 anaplastic meningioma subgroups.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Discover

Explore

Home ZAIA Blog